Comparing contaminants of emerging concern and microbial signatures of wastewater treated by membrane bioreactor and oxidation ditch methods

Abstract

Membrane bioreactors (MBRs) are an attractive option for upgrades to aging wastewater treatment infrastructure across the United States (U.S.) because they have a relatively small footprint and can handle various wastewater loading conditions. However, little is known regarding the efficiency with which MBRs can reduce contaminants of emerging concern (CECs) and microbial loads, or how they influence the microbiome of wastewater effluent. In 2022, we collected nine paired samples of primary treated effluent (PRI), secondary effluent treated by oxidation ditches (OXI), and secondary effluent treated by MBR from a facility in Minnesota, U.S. Samples were analyzed for CECs including 4 alkylphenol ethoxylates, 6 bisphenol analogues, 20 hormones, 110 pharmaceuticals, and 82 pesticides as well as heterotrophic bacteria counts (HPC) and microbiome communities. Except for pesticides, total sample concentrations of CEC classes in OXI and MBR effluents were similar and lower compared to PRI (p < 0.01). Pesticide concentrations were similar among all treatments. HPC was lower in MBR, compared to OXI, in 67% of samples. Despite limited differences in CEC signatures, differences in the microbiome between the two secondary treatments were observed. OXI showed more distinct differences in bacterial operational taxonomic unit (OTU) presence from PRI, compared to MBR. Relations between some contaminant groups (e.g., pharmaceuticals, bisphenols) and effluent microbiomes were observed, though most correlated with PRI effluent. Results from our study indicate that MBR is as effective as OXI at producing high-quality effluent and offers a viable alternative to conventional secondary treatment methods. This full-scale study provides data that helps fill knowledge gaps related to MBR performance outside of lab or benchtop experiments and direct comparison to OXI treatment.